Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise ...
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...
A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback